Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Oddone F, Kirwan J, Lopez-Lopez F, Zimina M, Fassari C, Holló G; VISIONARY Study Group. Oddone F, et al. Adv Ther. 2022 Aug;39(8):3501-3521. doi: 10.1007/s12325-022-02166-6. Epub 2022 May 7. Adv Ther. 2022. PMID: 35524840 Free PMC article.
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.
Garcia-Medina JJ, Benitez-Del-Castillo J, Rodríguez-Agirretxe I, Lopez-Lopez F, Moreno-Valladares A; VISIONARY Study Group (Spain). Garcia-Medina JJ, et al. J Ocul Pharmacol Ther. 2022 Apr;38(3):252-260. doi: 10.1089/jop.2021.0099. Epub 2022 Feb 28. J Ocul Pharmacol Ther. 2022. PMID: 35230148 Free PMC article.
Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy.
Oddone F, Scorcia V, Iester M, Sisto D, De Cilla S, Bettin P, Cagini C, Figus M, Marchini G, Rossetti L, Rossi G, Salgarello T, Scuderi GL, Staurenghi G; VISIONARY Study Group (Italy). Oddone F, et al. Clin Ophthalmol. 2022 Jun 1;16:1707-1719. doi: 10.2147/OPTH.S364880. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35677639 Free PMC article.
Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Oddone F, Kirwan J, Lopez-Lopez F, Zimina M, Fassari C, Holló G; VISIONARY Study Group. Oddone F, et al. Adv Ther. 2022 Aug;39(8):3522-3523. doi: 10.1007/s12325-022-02210-5. Adv Ther. 2022. PMID: 35731341 Free PMC article. No abstract available.